NCT01360125View on ClinicalTrials.gov

S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Leukemia
Interventions
GENETIC

proteomic profiling

OTHER

flow cytometry

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT01360125 - S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy | Biotech Hunter | Biotech Hunter